Cargando…
Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents
Helicobacter pylori is considered one of the most prevalent human pathogenic microbes globally. It is the main cause of a number of gastrointestinal ailments, including peptic and duodenal ulcers, and gastric tumors with high mortality rates. Thus, eradication of H. pylori is necessary to prevent ga...
Autores principales: | Al-Fakhrany, Omnia Momtaz, Elekhnawy, Engy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406680/ https://www.ncbi.nlm.nih.gov/pubmed/37550555 http://dx.doi.org/10.1007/s00203-023-03639-0 |
Ejemplares similares
-
Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets
por: Roszczenko-Jasińska, Paula, et al.
Publicado: (2020) -
Helicobacter pylori treatment: antibiotics or probiotics
por: Goderska, Kamila, et al.
Publicado: (2017) -
In Vivo and In Vitro Antimicrobial Activity of Biogenic Silver Nanoparticles against Staphylococcus aureus Clinical Isolates
por: Attallah, Nashwah G. M., et al.
Publicado: (2022) -
Anti-Biofilm and Antibacterial Activities of Cycas media R. Br Secondary Metabolites: In Silico, In Vitro, and In Vivo Approaches
por: Attallah, Nashwah G. M., et al.
Publicado: (2022) -
Traditional herbs against COVID-19: back to old weapons to combat the new pandemic
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)